• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未雨绸缪:社会和行为科学在生物医学 HIV 预防干预措施试验中的关键作用。

Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions.

机构信息

Laboratory of Infectious Disease Prevention, New York Blood Center, New York, NY 10065, USA.

出版信息

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S183-6. doi: 10.1097/QAI.0b013e31829a3a4d.

DOI:10.1097/QAI.0b013e31829a3a4d
PMID:23764634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3737568/
Abstract

A range of efficacies have been reported for biomedical HIV prevention interventions, including antiretroviral treatment, male circumcision, preexposure prophylaxis, microbicides, and preventive vaccines. This range of efficacies probably results from the influence of multiple inputs and processes during trials, including the strength and target of the intervention, host factors, target population characteristics, level of HIV exposure, and intervention dose. Expertise in social and behavioral sciences, in conjunction with basic science, clinical research, epidemiology, biostatistics, and community, is needed to understand the influence of these inputs and processes on intervention efficacy, improve trial design and implementation, and enable interpretation of trial results. In particular, social and behavioral sciences provide the means for investigating and identifying populations suitable for recruitment into and retention in trials and for developing and improving measures of HIV exposure and intervention dose, all within the larger sociocultural context. Integration of social and behavioral sciences early in idea generation and study design is imperative for the successful conduct of biomedical trials and for ensuring optimal data collection approaches necessary for the interpretation of findings, particularly in cases of unexpected results.

摘要

一系列生物医学 HIV 预防干预措施的疗效已被报道,包括抗逆转录病毒治疗、男性包皮环切术、暴露前预防、杀微生物剂和预防性疫苗。这种疗效范围可能是由于试验过程中多种因素和过程的影响,包括干预措施的强度和目标、宿主因素、目标人群特征、HIV 暴露水平和干预剂量。社会和行为科学方面的专业知识,结合基础科学、临床研究、流行病学、生物统计学以及社区知识,有助于了解这些因素和过程对干预效果的影响,改进试验设计和实施,并能对试验结果进行解释。特别是,社会和行为科学提供了调查和确定适合招募入组和维持试验的人群的方法,以及开发和改进 HIV 暴露和干预剂量的测量方法,所有这些都在更大的社会文化背景下进行。在想法产生和研究设计的早期阶段整合社会和行为科学,对于成功开展生物医学试验以及确保最佳的数据收集方法以解释研究结果至关重要,尤其是在出现意外结果的情况下。

相似文献

1
Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions.未雨绸缪:社会和行为科学在生物医学 HIV 预防干预措施试验中的关键作用。
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S183-6. doi: 10.1097/QAI.0b013e31829a3a4d.
2
Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities.将行为和生物医学研究整合到 HIV 干预措施中:挑战与机遇。
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S6-11. doi: 10.1097/QAI.0b013e318292153b.
3
Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities.将行为与社会科学研究纳入杀微生物剂临床试验:挑战与机遇
Am J Public Health. 2006 Jan;96(1):79-83. doi: 10.2105/AJPH.2004.043471. Epub 2005 Nov 29.
4
The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.艾滋病病毒预防的过去、现在与未来:为下一代艾滋病病毒预防整合行为、生物医学及结构干预策略。
Annu Rev Clin Psychol. 2009;5:143-67. doi: 10.1146/annurev.clinpsy.032408.153530.
5
Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.支持研发广泛中和抗体用于 HIV 治疗和预防的临床试验教育材料的行为和社会科学研究。
Clin Trials. 2021 Feb;18(1):17-27. doi: 10.1177/1740774520948042. Epub 2020 Aug 24.
6
The Roles of Behavioral and Social Science Research in the Fight Against HIV/AIDS: A Functional Framework.行为与社会科学研究在抗击艾滋病毒/艾滋病中的作用:一个功能框架。
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):371-381. doi: 10.1097/QAI.0000000000001399.
7
Translation of biomedical prevention strategies for HIV: prospects and pitfalls.HIV 生物医学预防策略的翻译:前景与陷阱。
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1(0 1):S12-25. doi: 10.1097/QAI.0b013e31829202a2.
8
Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence.推进社区利益相关者参与生物医学 HIV 预防试验:原则、实践和证据。
Expert Rev Vaccines. 2014 Dec;13(12):1553-62. doi: 10.1586/14760584.2014.953484. Epub 2014 Sep 1.
9
Biomedical HIV prevention--and social science.生物医学艾滋病预防——与社会科学。
Lancet. 2007 Jul 7;370(9581):10-1. doi: 10.1016/S0140-6736(07)61026-5.
10
Biomedical approaches to HIV prevention.预防艾滋病病毒的生物医学方法。
Alcohol Res Health. 2010;33(3):195-202.

引用本文的文献

1
Why did I participate in an HIV vaccine study? Experiences of participation in the first phase II HIV vaccine trial in Mozambique: An ancillary study using a mixed-method approach.我为什么参与一项HIV疫苗研究?参与莫桑比克首个II期HIV疫苗试验的经历:一项采用混合方法的辅助研究。
Vaccine X. 2024 Jun 6;19:100510. doi: 10.1016/j.jvacx.2024.100510. eCollection 2024 Aug.
2
The Evidence Project: Protocol for Systematic Reviews of Behavioral Interventions and Behavioral Aspects of Biomedical Interventions for HIV Prevention, Treatment, and Health Service Delivery in Low- and Middle-Income Countries.证据项目:针对在中低收入国家中预防、治疗和提供卫生服务的行为干预措施和生物医学干预措施的行为方面进行系统评价的方案。
AIDS Educ Prev. 2024 Apr;36(2):87-102. doi: 10.1521/aeap.2024.36.2.87.
3
Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa.南非男男性行为者中的性传播感染
PLOS Glob Public Health. 2023 Apr 5;3(4):e0001782. doi: 10.1371/journal.pgph.0001782. eCollection 2023.
4
Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.莫桑比克马普托市的高危年轻人表现出高度参与 HIV 试验的意愿:来自 HIV 疫苗准备队列研究的结果。
PLoS One. 2021 Dec 2;16(12):e0260126. doi: 10.1371/journal.pone.0260126. eCollection 2021.
5
"You Are on the Right Track With the App:" Qualitative Analysis of Mobile Phone Use and User Feedback Regarding Mobile Phone Sexual Risk Assessments for HIV Prevention Research.“你使用这款应用的方向是正确的:”关于用于艾滋病预防研究的手机性风险评估的手机使用情况及用户反馈的定性分析
Front Digit Health. 2021 Mar 22;3:576514. doi: 10.3389/fdgth.2021.576514. eCollection 2021.
6
A Web-Based Intervention to Reduce Decision Conflict Regarding HIV Pre-Exposure Prophylaxis: Protocol for a Clinical Trial.一项基于网络的干预措施以减少关于HIV暴露前预防的决策冲突:一项临床试验方案
JMIR Res Protoc. 2020 Jun 15;9(6):e15080. doi: 10.2196/15080.
7
Transgender Women's Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs).跨性别女性对潜在未来长效生物医学 HIV 预防策略的关注和偏好:以注射和植入式药物输送装置(IMDDs)为例。
AIDS Behav. 2020 May;24(5):1452-1462. doi: 10.1007/s10461-019-02703-5.
8
Efficacy of a Small-Group Intervention for Post-Incarcerated Black Men Who Have Sex with Men and Women (MSMW).监禁后与男男性行为者和女性发生性行为的黑人男性小型团体干预的效果。
J Urban Health. 2018 Apr;95(2):159-170. doi: 10.1007/s11524-018-0227-9.
9
Recruitment of Underrepresented Minority Researchers into HIV Prevention Research: The HIV Prevention Trials Network Scholars Program.招募代表性不足的少数族裔研究人员参与艾滋病预防研究:艾滋病预防试验网络学者计划。
AIDS Res Hum Retroviruses. 2018 Feb;34(2):171-177. doi: 10.1089/AID.2017.0093. Epub 2017 Dec 20.
10
Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities.长效艾滋病预防措施实施的前期规划:挑战与机遇
Curr Opin HIV AIDS. 2015 Jul;10(4):290-5. doi: 10.1097/COH.0000000000000159.

本文引用的文献

1
Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.MTN 001 研究:每日口服和局部应用替诺福韦预防女性 HIV 感染的随机交叉试验中的依从性和可接受性。
AIDS Behav. 2013 Feb;17(2):737-47. doi: 10.1007/s10461-012-0333-8.
2
Preexposure prophylaxis for HIV infection among African women.预防非洲女性感染 HIV 的暴露前预防措施。
N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.
3
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.抗逆转录病毒预防治疗用于异性恋男性和女性的 HIV 预防。
N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.
4
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.作为协变量的风险行为和时间对 HIV 疫苗方案 ALVAC-HIV(vCP1521) 和 AIDSVAX B/E 疗效的影响:泰国 3 期疗效试验 RV 144 的事后分析。
Lancet Infect Dis. 2012 Jul;12(7):531-7. doi: 10.1016/S1473-3099(12)70088-9. Epub 2012 May 30.
5
Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study.男男性行为者参与的随机 HIV-1 疫苗功效试验中的性行为风险行为、割礼状况和腺病毒 5 型预先存在的免疫力:步骤研究。
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):405-13. doi: 10.1097/QAI.0b013e31825325aa.
6
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.解析 HIV 预防的暴露前预防试验结果为何出现分歧。
AIDS. 2012 Apr 24;26(7):F13-9. doi: 10.1097/QAD.0b013e3283522272.
7
HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study.HIV 发生率及乌干达马萨卡地区 HIV 不一致夫妇感染 HIV 的风险因素:HIV 疫苗准备研究。
PLoS One. 2011;6(8):e24037. doi: 10.1371/journal.pone.0024037. Epub 2011 Aug 31.
8
Conceptual framework for behavioral and social science in HIV vaccine clinical research.用于 HIV 疫苗临床研究的行为与社会科学概念框架。
Vaccine. 2011 Oct 13;29(44):7794-800. doi: 10.1016/j.vaccine.2011.07.108. Epub 2011 Aug 5.
9
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
10
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.男男性行为人群 HIV 预防的暴露前药物预防。
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.